معرفی
Yihai Cao is a Professor at MTC, Karolinska Institutet, Stockholm, Sweden, holding this position since 2004 after serving as Associate Professor (2001-2004) and Assistant Professor (1998-2001) at the same institution. His academic career spans prestigious institutions including Harvard Medical School where he completed postdoctoral training under Professor Judah Folkman (1993-1996), and he earned his Ph.D. in Cell Biology and Cancer Research from Karolinska Institutet in 1993.
His educational journey includes:
- 1993-1996: Postdoc, Harvard Medical School, Laboratory of Cancer Biology and Vascular Biology (Dr. Judah Folkman’s Laboratory), Department of Surgery and Cell Biology, Harvard Medical School and Children's Hospital, Boston, Mass. USA
- 1993: Ph.D. in Cell Biology and Cancer Research, the Ludwig Institute-Karolinska Institutet, Stockholm, Sweden
- 1988-1993: Ph.D. study, The Ludwig Institute for Cancer Research, Karolinska Institutet
- 1986-1988: Visiting Scientist, Laboratory of Molecular Biology, Ludwig Institute for Cancer Research, Bern Branch, Switzerland
- 1983-1986: Institute of Hematology, Chinese Academy of Medical Sciences, China
- 1978-1983: Study clinical medicine at Shandong Medical College
- Doctoral Degrees: Ph.D. in Medical Sciences-Cell and Molecular Biology (1993, Karolinska Institutet); Honorary M.D. (2006, Copenhagen University, Denmark)
Professor Cao's research centers on Angiogenesis, Drug Development, Tumor Biology, Vascular Biology, and Metabolism, with groundbreaking contributions to antiangiogenic therapy development. His work bridges fundamental vascular biology with clinical applications, particularly in cancer treatment and ocular disease therapeutics, demonstrating exceptional translational impact through patented inventions and biotech ventures. He maintains active leadership in international scientific discourse through extensive conference participation and editorial roles.
His distinguished honors include:
- ERC advanced research grant (ERC_Ad)
- The Dr. Axel Hirsch Prize for medicine
- NOVO Nordisk Advanced grant award
- Distinguished professor award (Karolinska Institute)
- Eric Fernström Prize, Sweden
- Fulbright research fellow award (USA)
- Human Frontier Science Program fellow
- Chang Jiang Scholar, Chinese Educational Ministry
- Multiple honorary professorships across Europe and Asia
Professor Cao maintains robust research leadership through substantial grant funding including ERC advanced research grants, EU FP7 Metoxia, EU FP6 (Vascuplug), Human Frontier Science Program, and NOVO Nordisk Foundation grants. He has mentored 14 graduated Ph.D. students as primary supervisor, currently guides 2 Ph.D. candidates and 10 postdocs, and has mentored over 40 postdoctoral researchers globally. His scientific influence extends through editorial leadership as Editor-in-Chief of Vascular Cell and service on international grant review panels for INSERM (France), MRC (UK), SNSF (Switzerland), and Chinese NSF. His entrepreneurial impact is demonstrated through biotech ventures Clanotech (focused on ocular disease therapeutics) and Swenora (spinal cord injury treatments), supported by 60 internationally patented inventions in angiogenesis therapeutics.
Professor Cao maintains active international collaborations through honorary appointments at Copenhagen University, Peking University, Shandong University, Nankai University, Leicester University, and Linköping University, while continuing translational research through his laboratory at Karolinska Institutet and ongoing biotech development efforts.
